Low-Dose Alfacalcidol Controls Secondary Hyperparathyroidism in Predialysis Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|114|4|c268-c276

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.114, Iss.4, 2010-01, pp. : c268-c276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneuos findings in patients with predialysis chronic kidney disease

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1609-1613

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using prophylactic proton pump inhibitor

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 478-484

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective

By Nuijten Mark   Andress Dennis L.   Marx Steven E.   Sterz Raimund  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1221-1234

Informa Healthcare

Access to resources Recommend Favorite

Secondary Hyperparathyroidism Is Associated with Higher Cost of Care among Chronic Kidney Disease Patients with Cardiovascular Comorbidities

By  

Nephron Clin Pract, Vol. 105, Iss. 4, 2007-01 ,pp. : c159-c164

Karger

Access to resources Recommend Favorite

Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 120, Iss. 3, 2012-06 ,pp. : c147-c155

Karger

Access to resources Recommend Favorite